Teladoc Health, Inc. TDOC
Teladoc Health, Inc. statistics & valuation
Market cap$1.5B
P / S0.6×
P / B1.1×
P / FCF5.3×
Net margin-7.9%
Return on equity-14.5%
FCF margin11.3%
Return on capital-10.7%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | 69.2% | 73.6% | 74.0% |
| Operating margin | -10.4% | -39.7% | -9.6% | -567.3% | -13.1% | -46.3% | -14.5% | -17.0% | -32.3% | -50.9% |
| Net margin | -7.9% | -39.0% | -8.5% | -567.5% | -21.1% | -44.3% | -17.9% | -23.2% | -45.8% | -60.3% |
| FCF margin | 11.3% | 11.0% | 13.0% | 7.2% | 9.1% | -5.3% | 4.8% | -2.1% | -15.9% | -43.8% |
| Return on assets | -7.0% | -28.5% | -5.0% | -314.3% | -2.4% | -2.7% | -6.2% | -6.4% | -13.0% | -24.4% |
| Return on equity | -14.5% | -67.1% | -9.5% | -591.9% | -2.7% | -3.1% | -9.7% | -9.6% | -19.1% | -32.1% |
| Debt / equity | — | — | — | — | — | — | — | — | — | 0.19× |
| Current ratio | 2.77 | 1.77 | 3.54 | 3.29 | 3.70 | 3.19 | 6.52 | 8.53 | 3.87 | 3.93 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.